Real-world observational data show lower cardiovascular events risks during the period leading up to dialysis initiation among erythropoietin vs roxadustat users. Erythropoietin is associated with ...
Detailed price information for Fibrogen Inc CS (FGEN-Q) from The Globe and Mail including charting and trades.
Shares of FibroGen, Inc. (NASDAQ:FGEN) climbed about 3% on Monday after the company said its drug candidate roxadustat has been granted Orphan Drug Designation by the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback